Many studies have suggested that IGF-1 is involved in the development of breast cancer [46–48], is associated with an increased risk of premenopausal breast cancer [49], and has poor prognosis [50] including decreased breast cancer-specific survival [51]. The gene discussed is IGF1; the disease is breast carcinoma.